tbuckley/cabot-search huggingface dataset:
EP08.03-01 Copy Number Variants and Late Somatic Mutations Underlying Tumor Progression in NADIM Clinical Trials
Authors: R. Serna Blasco, M.R. García Campelo, E. Nadal, P. Mediavilla, V. Calvo, J.L. Gonzalez-Larriba, L. Robado de Lope, B. Massutí, A. Martinez-Marti, J. Casal, M. Dómine, M. Cobo, A. Cruz, A. Romero, M. Provencio
Journal: Journal of Thoracic Oncology (2023)
P1.10-01 Enrichment of FA/HR Aberrations inATM/ATR-mutated NSCLC Was Accompanied by Distinct Molecular Features and Poor Prognosis
Authors: W. Wei, F. Shi, Y. Xu, Y. Jiao, Y. Zhang, Q. Ou, X. Wu, M. Zhu, Y. Shao, L. Yang, J. Lai
Journal: Journal of Thoracic Oncology (2023)
EP12.01-22 Evaluation of the LITE-Risk Prognostic Model in Consolidation Durvalumab and Osimertinib-Treated NSCLC
Authors: A. Gibson, M. Dean, D.Y. Heng, D.E. Meyers, Y. Ruan, R. Sangha, I. Stukalin, W.Y. Cheung, V. Navani
Journal: Journal of Thoracic Oncology (2023)
P1.28-11 Recurrence Dynamics for Pathological N2 Non-small Cell Lung Cancer depending on the IASLC Residual Tumor Descriptor
Authors: I.H. Kim, J.K. Yun, G.D. Lee, S. Choi, H.R. Kim, Y.-H. Kim, D.K. Kim, S.-I. Park
Journal: Journal of Thoracic Oncology (2023)
EP12.01-07 Brigatinib Restores Disease Control at Second Progression on Osimertinib in Metastatic EGFR ex19del Mutated NSCLC with Acquired EML4-ALK Fusion
Authors: E.M. Urbanska, J.B. Sørensen, M. Grauslund, J.O. Löfgren, E. Santoni-Rugiu
Journal: Journal of Thoracic Oncology (2023)
P1.21-11 Immunotherapy Response Score (IRS) Predicts Pembrolizumab Clinical Benefit in Patients with NSCLC in TPS≥50%
Authors: J. Suga, S. Thomas, N. Achacoso, C. Jiang, E. Chung, A. Solorzano-Pinto, P. Tse, B.J. Bulen, N.A. Khazanov, L.E. Lamb, D.H. Hovelson, K. Kwiatkowski, D.B. Johnson, D.R. Rhodes, S.A. Tomlins, L.A. Habel
Journal: Journal of Thoracic Oncology (2023)
P1.27-04 Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Bronchioloalveolar Carcinoma of the Lung
Authors: Y.K. Chae, M. Othus, S.P. Patel, D.E. Gerber, T. Tanvetyanon, L.I.-Y. Chung, H.S. Kim, C.M. McLeod, H.X. Chen, E. Sharon, H. Streicher, C.W. Ryan, C.D. Blanke, R. Kurzrock
Journal: Journal of Thoracic Oncology (2023)
P2.01-06 NAUTIKA1 Study: Preliminary Efficacy and Safety Data with Neoadjuvant Alectinib in Patients with Stage IB-III ALK+ NSCLC
Authors: J.M. Lee, E.M. Toloza, H.I. Pass, B.E. Johnson, J.V. Heymach, L. Sholl, A. Saqi, W.D. Travis, I. Wistuba, J. Lin, M.G. Kris, A.I. Spira, C.A. Shu, A.N. Saltos, B. Ding, K. Schulze, Q. Zhu, C. Ngiam, I. Bara, J.E. Chaft
Journal: Journal of Thoracic Oncology (2023)
P2.09-15 Real World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer
Authors: K.I. Zhou, C. Lin, C.-L. Tseng, N. Ramnath, J.E. Dowell, M.J. Kelley
Journal: Journal of Thoracic Oncology (2023)
EP07.01-10 Risk assessment of severe pulmonary complications leading to death or oxygen therapy after lung resection in patients with primary lung cancer
Authors: S. Otani, T. Ueki, T. Ishimura, T. Sugihara, Y. Kiriyama, Y. Mori, N. Sakao, K. Yamada, Y. Sano, H. Izutani
Journal: Journal of Thoracic Oncology (2023)
EP09.04-03 Survival of Non-small Cell Lung Cancer with and without Brain Metastasis - Shifting to a Merging Survival Curves Era
Authors: I. Averbuch, A. Zer, R. Tschernichovsky, S. Yust-Katz, O. Rotem, D. Limon, O. Gal
Journal: Journal of Thoracic Oncology (2023)
P2.18-06 Co-designing an Experience of Care and Quality of Life Survey for an Australian Mesothelioma Clinical Outcomes Registry
Authors: S. Harden, C. O'Callaghan, D. Samankula, M. Brand, V. Hamilton, B. Healy, K. Healy, J. Philip, R. Stirling, J. Zalcberg, P. Schofield
Journal: Journal of Thoracic Oncology (2023)
EP11.03-08 Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years
Authors: H. Horinouchi, Y. Ohe, Y. Yamanaka, T. Kurata, K. Watanabe, Y. Hosomi, Y. Nakahara, T. Asao, S. Saeki, Y. Tsubata, Y. Fujita, J.S. Konishi, H. Mizugaki, M. Ohuchi, S. Yagishita, A. Hamada
Journal: Journal of Thoracic Oncology (2023)
EP09.05-01 Ionizing Radiation Induces Vascular Smooth Muscle Cell Senescence through Activating NF-κB/CTCF/p16 Pathway
Authors: F. Tong, X. Zheng, Z. Liu, None y. bin, J. Wang, X. Rao, G. Wu, X. Dong
Journal: Journal of Thoracic Oncology (2023)
MA11.09 SAKK 16/18: Neoadjuvant Chemotherapy, Durvalumab and Immune-Modulatory RT in Stage III(N2) NSCLC. Surgical Interim Analysis
Authors: P. Dorn, L. Holer, D. Lardinois, A. Dutly, W. Karenovics, J. Habicht, J.A. Lutz, H. Gelpke, I. Opitz, S. Haefliger, D. König, M. Früh, A. Addeo, C. Vonder Mühll-Schill, A. Bettini, B. Scheibe, S. Savic Prince, M. Guckenberger, T. Finazzi, S.I. Rothschild, L.A. Mauti
Journal: Journal of Thoracic Oncology (2023)
P1.02-06 Glucose Deprivation Promotes Pseudo-Hypoxia and De-differentiation in Lung Adenocarcinoma
Authors: P. Saggese, A. Pandey, E. Fung, A. Hall, J. Yanagawa, E.F. Rodriguez, T.R. Grogan, G. Giurato, G.R. Nassa, A. Salvati, G. Giurato, S.M. Dubinett, C. Scafoglio
Journal: Journal of Thoracic Oncology (2023)
EP07.04-01 Free Circulating and Extracellular Vesicles-Derived microRNA as Prognostic Biomarkers in Resected Early-Stage NSCLC: RESTING Study Results
Authors: L. Pasini, E. Petracci, M. Urbini, E. Felip, F. Stella, M. Tebaldi, I. Azzali, A. Martinez-Marti, E. Pancreach, F. Davoli, M. Salvi, M. Beau, P. Solli, G. Lai, R. Amat, C. Carbonell, A. Delmonte, L. Crinò, P. Ulivi
Journal: Journal of Thoracic Oncology (2023)
P2.03-03 Upfront or Delayed Cranial RT in Oncogene Mutated NSCLC with Asymptomatic Brain Metastases: A Phase III Randomized Controlled Trial
Authors: A. Tibdewal, J.P. Agrawal, R. Nabariya, K. Prabhash, N. Mummudi, R. Miriyala, V. Noronha, V. Patil, N. Purandare, R. Kaushal, T. Pai, A. Janu
Journal: Journal of Thoracic Oncology (2023)
EP12.01-64 Metastatic Non-Small Cell Lung Cancer With EGFR Mutations: Treatment Pattern and Outcomes From a Systematic Literature Review
Authors: S. Gadgeel, E. Wang, S. Phani, C. Wu, M. Salas, J. Meng, F. Diamand, S. Esker, D.W.-T. Lim
Journal: Journal of Thoracic Oncology (2023)
MA02.03 Incidentally-Detected Lung Cancer in Individuals Who Smoked v Never Smoked in a US Cohort
Authors: M. Smeltzer, W. Liao, N.R. Faris, C. Fehnel, J. Goss, C.J. Shepherd, T. Qureshi, S. Peppers, A. Harris, A. Porter, M.A. Ray, A.T. Matthews, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2023)
P1.13-04 The LuCID Study: Detection of Lung Cancer Breath Biomarkers via Breath Biopsy in a Multi-Centre Trial
Authors: M.v.d. Schee, M. Allsworth, Y. Chen, A. de Saedeleer, M. Leal, S. Dragonieri, H. Wirtz, M. Gaga, A. Scherpereel, A. Prasad, M. Haris, S. Grundy, W. Ricketts, L. Fuller, J. Facenda, J. Bennet, S. Chee, A. Barlow, A. Wight, V. Conteh, M. Ledson, E. Mishra, A. Bhatta, M. Weatherhead, P. Crosbie, J. Wrightson, S. Janes, D. Baldwin, B. Boyle, R. Rintoul
Journal: Journal of Thoracic Oncology (2023)
EP11.02-07 Dostarlimab + CT vs Pembrolizumab + CT in Metastatic Non-Squamous NSCLC: Asian Subgroup Analyses of the PERLA Trial
Authors: D.H.E. Lee, J.S. Ahn, S.-H. Lin, A.L. Ortega Granados, C.S. Fuentes, C.-F. Chian, Z. Szijgyarto, N. Stjepanovic, L. Cho, S.M. Lim
Journal: Journal of Thoracic Oncology (2023)
P2.08-01 TROPION-Lung08: Datopotamab Deruxtecan Plus Pembrolizumab in Untreated Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC)
Authors: C. Zhou, B.P. Levy, J. Sands, S. Parakh, S. Sugawara, K. Syrigos, J.S. Ahn, M. Zhao, C.-C. Lin, E. Felip, F. Cappuzzo, M. Reck, J.C.H. Yang, R. Joseph, S. Rawat, J. Xie, I. Okamoto
Journal: Journal of Thoracic Oncology (2023)
P2.13-06 A Novel Clinical Scoring System (EAST score) for the Prediction of Treatment Response in Limited-Stage Small-Cell Lung Cancer
Authors: Y. Ito, Y. Zenke, T. Sakai, Y. Shibata, H. Izumi, K. Nosaki, S. Umemura, S. Matsumoto, K. Yoh, M. Nakamura, H. Hojo, T. Izumo, K. Goto
Journal: Journal of Thoracic Oncology (2023)
EP06.02-02 Enrichment for PD-L1 High Tumors in AXL-Expressing Advanced Non-small Cell Lung Cancer (NSCLC)
Authors: M. Awidi, J. Qiu, A. Frazer, C. Janes, A. Dozier, H. Chen, P. Jain, E. Yau, G.K. Dy
Journal: Journal of Thoracic Oncology (2023)
EP10.01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET Antibody-Drug Conjugate, in Patients with MET-Overexpressing NSCLC
Authors: A. Drilon, M.M. Awad, D.R. Camidge, P.M. Forde, M. Alexander, S.M. Gadgeel, L.C. Villaruz, J. Perez, T. Navas, C. Daly, S. Patel, S. Li, M. Laughlin, I. Lowy, H. Magnan, P. Rietschel
Journal: Journal of Thoracic Oncology (2023)
EP12.01-57 Unresectable Advanced NSCLC Transformed to Resectable NSCLC through Effective Aumolertinib Neoadjuvant Therapy: A Case Report
Authors: C. Chen, Y. Wang, G. Xu, Y.X. Song, Y. Tang, L.B. Liang, Q. Li, X. Zhang, X.C. Yang, L.N. Guo
Journal: Journal of Thoracic Oncology (2023)
EP06.05-10 Clinical Value of Baseline Plasma Epstein-Barr Virus DNA in Advanced Primary Pulmonary Lymphoepithelioma-like Carcinoma
Authors: Y. Liang, Q.-H. Zou, Y.-B. Lin, L.-P. Kang, C.-W. Huang, J.-L. Mai
Journal: Journal of Thoracic Oncology (2023)
MA04.06 Epigenomic Drug Effect on Osimertinib-Induced Drug Tolerant Persister in a Lung Cancer Patient-Derived Xenograft Model
Authors: Y. Inoue, Q. Li, N.-A. Pham, K. Hueniken, M. Li, A. Arivajiagane, T. Koga, H. Ogawa, M. Mikubo, M.-S. Tsao
Journal: Journal of Thoracic Oncology (2023)
P2.05-07 Roles of p53 and AXL Expressions on the Efficacy of ICI-Based Therapy in Patients with EGFR Mutated Lung Cancer after Osimertinib
Authors: T. Yamada, K. Morimoto, K. Azuma, Y. Goto, T. Harada, S. Shiotsu, N. Tamiya, Y. Chihara, T. Takeda, O. Hiranuma, I. Hasegawa, K. Takayama
Journal: Journal of Thoracic Oncology (2023)
P2.10-03 Mechanisms of Acquired Resistance to ALK Inhibitors Using Plasma Sequencing - Preliminary Data from the ATORG004 Study
Authors: A.C. Tan, A.O.L. Seet, D.-W. Kim, G.F. Ho, J. Ho, B.-C. Liao, L.M. Tho, A.R. Ahmad, T. Reungwetwattana, Y. Goto, N. Sandhir, S.S. Hsing, D.H. Lee, H. Loong, D.S.W. Tan
Journal: Journal of Thoracic Oncology (2023)
P1.04-02 Ablative Radiation Induces Distinct Sequential Waves of Mitotic and Innate Immune Death Regulated through DNA Repair Pathways
Authors: H. Gee, R. Szmyd, S. Casolin, L. French, C. Nelson, A.G. Manjon, H. Shen, E. Hau, T. Cesare
Journal: Journal of Thoracic Oncology (2023)
EP12.01-18 Validation of the ALK-Brain Prognostic Index (ALK-BPI) Model in Patients with ALK-rearranged Non-small Cell Lung Cancer and Brain Metastases
Authors: G. Tsakonas, C. Kamali, I. Zerdes, A. Koulouris, P. Hydbring, P. Christopoulos
Journal: Journal of Thoracic Oncology (2023)
MA20.09 Baseline PD-L1+ Neutrophils and Monocytes Predict Radiological Response to Anti-PD-(L)1 Therapy in Patients with Advanced NSCLC
Authors: M. Majem, M. Mulet, G. Anguera, R.Q. Osuna, A. Barba, E. Canto, J. Serra, J. Alejandre, I. Sullivan, S. Martinez, S. Vidal
Journal: Journal of Thoracic Oncology (2023)
EP11.03-18 Optimal Duration of Immune Checkpoint Inhbitors in Non-small Cell Lung Cancer: Less Is More?
Authors: M. Blanco Clemente, A. Collazo-Lorduy, V. Calvo de Juan, V. Ospina Serrano, J.C. Sánchez González, B. Núñez García, A. Royuela, M. Martínez Cutillas, Y. Garitaonaindia Díaz, C. Traseira Puchol, R. Aguado Noya, D. Ruiz de Domingo, M. Provencio Pulla
Journal: Journal of Thoracic Oncology (2023)
P1.12-10 Sensitization of Cancer Cells to Tumor Treating Fields (TTFields) via Inhibition of the PI3K/AKT Signaling Pathway
Authors: A. Klein-Goldberg, T. Voloshin, E. Zemer-Tov, R. Paz, L. Somri-Gannam, A. Volodin, L. Koren, K. Wainer-Katsir, A. Haber, M. Giladi, U. Weinberg, Y. Palti
Journal: Journal of Thoracic Oncology (2023)
EP11.03-37 Efficacy and Safety of Chemotherapy Plus Immunotherapy and Recombinant Human Endostatin in Advanced Non-small-Cell Lung Cancer
Authors: Y.-F. Zhu, M.-F. Ye, Y.-Y. Zeng, Z.-H. Huang, X.-L. Zhang, W.-C. Cen, S. Su
Journal: Journal of Thoracic Oncology (2023)
P1.21-09 Radiomic Signature of Identifies Outcome and Prognosis to Immune Checkpoint Inhibitors (ICI) in PD-L1 Low Non-small Cell Lung Cancer (NSCLC)
Authors: A. Hiremath, K. Bera, A. Gupta, V. Velcheti, A. Madabhushi, N. Braman
Journal: Journal of Thoracic Oncology (2023)
EP12.01-52 A Multi-Center Observational Study of Effectiveness and Safety of First Line Afatinib in Major Uncommon EGFR mutated NSCLC
Authors: A.T. Le, H.D.T. Vuong, L.V. Pham, H.M. Nguyen, P.C. Pham, H.T.T. Nguyen, K.T. Nguyen, T.T.A. Hoang, T.V. Pham, G.H. Nguyen, K.V. Dang, T.D.N. Nguyen, N.Q. Nguyen
Journal: Journal of Thoracic Oncology (2023)
OA17.06 The Predictive Value of PD-L1 levels on Circulating Stromal Cells in Unresectable Stage 3 NSCLC Treated with Chemoradiation
Authors: S. Lin, A. Seo, T. Xu, A. Tsao, J.V. Heymach, Z. Liao, J.Y. Chang, K.P. Gardner, J.A. Moran, C.-M. Tang, D.L. Adams
Journal: Journal of Thoracic Oncology (2023)
MA14.04 Prospective Trial of an EMR-based Nudge to Increase Molecular Genotyping in Newly Diagnosed Metastatic Non-squamous NSCLC
Authors: M.E. Marmarelis, D.G. Scholes, T.L. McWilliams, W.-T. Hwang, J.A. Kosteva, M.R. Costello, L.L. Sun, A.P. Singh, K.S. Lau-Min, A. Doucette, P.E. Gabriel, A.O. Martella, M. Roy, J.C. Thompson, R.B. Cohen, D.W. Dougherty, L.N. Shulman, C.J. Langer, J.E. Bekelman, E.L. Carpenter, C. Aggarwal
Journal: Journal of Thoracic Oncology (2023)
P2.09-18 FURVENT, Phase 3 Trial Testing Furmonertinib vs Chemotherapy as First-Line Treatment for Advanced NSCLC with EGFR exon 20 Insertions
Authors: A.I. Spira, B.C. Cho, E. Felip, E.B. Garon, K. Goto, M.L. Johnson, N.B. Leighl, A. Passaro, D. Planchard, S. Popat, J. Yang, X. Lu, Y. Jiang, J. Huang, M. Lam, M. Kowanetz, S. Wang, J. Le, J.Y. Hsu, C. Zhou
Journal: Journal of Thoracic Oncology (2023)
P1.22-10 RET Fusion (RETfus+) Driven Non-Small Cell Lung Cancer (NSCLC): AComprehensive Genomic Profiling (CGP) Study with Histologic Correlation
Authors: P.A. Kumar, A. Basnet, D.C. Pavlick, R.S.P. Huang, D.I. Lin, N. Danziger, J.S. Ross, S. GRAZIANO
Journal: Journal of Thoracic Oncology (2023)
EP11.03-39 Platinum/Taxane versus Docetaxel +/- Ramucirumab for Metastatic Lung Cancers That Progressed on Platinum Doublets and Anti-PD1/PD-L1
Authors: K. Qin, K. Wang, S. Li, L. Hong, R. Waree, S. Hubert, X. Le, N. Vokes, M. Altan, D.L. Gibbons, J. Heymach, J.J. Lee, Y. Lou, J. Zhang
Journal: Journal of Thoracic Oncology (2023)
P1.23-01 ctDNA Positivity Is a Clinical Prognosis Biomarker in Patients with EGFR ex20ins+ NSCLC
Authors: S. Chatterjee, X. Tong, Z. Su, Y. Li, M. Guha, E.N. Churchill, R.J. Fram, S. Vincent
Journal: Journal of Thoracic Oncology (2023)
EP07.04-10 Early-Stage EGFR Mutated NSCLC: Outcomes After Surgical Resection at a Large Academic Medical Center
Authors: C. Vakkalagadda, D. Dressler, J. Fuchs, N. Katam, M. Gurley, N. Mohindra, Y.K. Chae, L. Ferris, A. Wan, A. Ragam, S. Kim, A. Bharat, D. Odell, J. Patel
Journal: Journal of Thoracic Oncology (2023)
P1.25-05 Real-World Outcomes in Non-metastatic Non-small Cell Lung Cancer (NSCLC): An I-O Optimise Multi-Country Analysis
Authors: M.J. Daumont, C. Rault, H. Baltus, P.Q. Ding, G. Emanuel, S. Lucherini, L. Vo, A. Greystoke, A. Katalinic, C. Leal, M. Muwaffak, G.N. Oskarsdottir, A. Waldmann, G. Wagenius, W.Y. Cheung, R. Munro, M.J. Schoemaker
Journal: Journal of Thoracic Oncology (2023)
P2.09-11 JIN-A04, Highly Effective and Brain-penetrant Tyrosine Kinase Inhibitor Targeting HER2 Exon20 Insertion Mutations in NSCLC
Authors: M.R. Yu, M.R. Yun, H.B. Cho, H.B. Choi, G. Dong, S.J. Choi, S.Y. Oh, E.J. Lee, K.B. Duggirala, K. Lee, J.B. Lee, S.M.M. Lim, M.H. Hong, A. Jo, E. Seah, C. Kim, B.C. Cho
Journal: Journal of Thoracic Oncology (2023)
P1.20-01 Computed Tomography-based Deep Learning Model for Spread Through Air Spaces Prediction in Ground-Glass Predominant Lung Adenocarcinoma
Authors: M.-W. Lin, L.-W. Chen, S.-M. Yang, M.-S. Hsieh, Y.-H. Lee, J.-S. Chen, Y.-C. Chang, C.-M. Chen
Journal: Journal of Thoracic Oncology (2023)
P2.25-04 Unmet Social Needs and Spiritual Well-Being of Lung Cancer Surgery Patients and Family Caregivers from the United States
Authors: D. Teteh, O. Okunowo, B. Ferrell, L. Erhunmwunsee, D. Raz, S. Montgomery, R. Kittles, J. Kim, V. Sun
Journal: Journal of Thoracic Oncology (2023)
P2.27-03 Perception of Benefits and Risks of Treatments in Patients with Metastatic NSCLC with EGFRex20ins
Authors: M. Horn, E. Curran, J. Seo, M. Venkatraman, H.M. Lin, S. Ang, F. Pompilus, J.A. Whitty, J. Zhang, T. Mekhail
Journal: Journal of Thoracic Oncology (2023)
P2.02-05 Comprehensive Pneumonitis Assessment Among Inoperable Stage III NSCLC Patients Treated with Chemoradiotherapy-Immunotherapy Regimen
Authors: J. Paragas, M. Duclos, L. Alvarado, F. Cabrera, D. Mahmoud, S. Alshehri, I. Gerard, A. Joseph, N. Kopek, S. Faria, E. Zhang, B. Shieh, S. Owen, L. Ofiara, B. Abdulkarim
Journal: Journal of Thoracic Oncology (2023)
EP08.02-37 Definitive Hypofractionated Radiation Therapy with or without Immunotherapy for Stage IIb-III NSCLC: An Institutional Experience
Authors: B. Hopkins, D. Qian, A. Kesarwala, B. Stokes, J. Shelton, C. Steuer, J. Carlisle, T. Leal, S. Ramalingam, K. Higgins, S. Tian
Journal: Journal of Thoracic Oncology (2023)
MA03.03 Does Smoking Status Affect Survival After Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer?
Authors: N.D. Wallace, M. Alexander, S. Xie, D. Ball, B. Solomon, N. Plumridge, M. Shaw, S. Harden, F. Hegi-Johnson, S. Siva, T. John, A. Officer, M. MacManus
Journal: Journal of Thoracic Oncology (2023)
EP11.01-01 Final Analysis of First-Line Chemo-Immunotherapy in Patients with Advanced Lung Adenocarcinoma: An Italian Real-World Study
Authors: A. Leonetti, F. Perrone, M. Puntoni, P. Bordi, G. Maglietta, E. Bria, F. Gelsomino, A. Gelibter, E. Caliman, C. Genova, G. Guaitoli, F. Passiglia, M. Montrone, S. Oresti, G. Pasello, E. Roca, S. Pilotto, F.L. Cecere, A. Guida, A. Manzo, A. Russo, F. Rastelli, A. Bulotta, F. Citarella, L. Toschi, F. Zoratto, D.L. Cortinovis, F. Paoloni, A. Follador, A. Carta, A. Camerini, M. Di Maio, M. Tiseo
Journal: Journal of Thoracic Oncology (2023)
MA15.10 Phase II Study of Nivolumab Plus Ipilimumab with Chemotherapy for Advanced NSCLC with Untreated Brain Metastases: NIke Trial (LOGiK2004)
Authors: Y. Tsuchiya-Kawano, Y. Shiraishi, M. Tachihara, R. Saito, T. Okamoto, N. Sugasaki, K. Nakatomi, F. Kiyomi, I. Okamoto
Journal: Journal of Thoracic Oncology (2023)
EP01.01-21 Respirable Crystalline Silica Exposure and Lung Cancer Risk: A Review of Cut-off Points
Authors: J. Rey Brandariz, M. Pérez Ríos, C. Candal Pedreira, C. Martínez, L. Varela-Lema, A. Ruano-Ravina
Journal: Journal of Thoracic Oncology (2023)
P2.28-03 Symptomatic vs. Asymptomatic SARS-CoV-2 Infection Rates in Lung Cancer: Longitudinal Nucleocapsid Antibody Analysis
Authors: A. Rodilla, R.M. Valanparambil, P.C. Mack, C.-Y. Hsu, S. Tavolacci, J.M. Carreño, R. Brody, A. Moore, J.C. King, J.E. Gomez, N. Rohs, C.D. Rolfo, D.E. Gerber, J.D. Minna, P.A. Bunn, A. García-Sastre, F. Krammer, S. Ramalingam, Y. Shyr, R. Ahmed, F.R. Hirsch
Journal: Journal of Thoracic Oncology (2023)
MA21.09 More Accurate Staging of Stage IV Lung Cancer Through EUS B of the Left Adrenal Gland
Authors: F. Oezkan, H. Hautzel, M. Seweryn, A. Voulgaris, F. Uzer, J. Winantea, R. Karpf-Wissel, F. Funke, M. Opitz, W.E.E. Eberhardt, M. Metzenmacher, M. Wiesweg, M. Schuler, S. Bölükbas, D. Theegarten, K. Darwiche
Journal: Journal of Thoracic Oncology (2023)
EP12.02-10 Personalizing Care for Patients with Advanced ALK+ NSCLC through a Blended Continuing Education and Quality Improvement Initiative
Authors: J. Kim, L. Gracie-King, M. Viens, J. Timko, V. Ocana, M. Chivukula, M. Tismenetsky, M. Hooper, S. LaBuda, D.R. Camidge
Journal: Journal of Thoracic Oncology (2023)
P1.23-09 Cerebrospinal Fluid ctDNA Based Therapy Associated with Survival of CNS Metastases in Advanced NSCLC: A Large Scale, Comprehensive Study
Authors: M.-M. Zheng, L.-B. Tang, H.-Y. Tu, B.-Y. Jiang, K. Yin, J.-J. Yang, X.-C. Zhang, Y. Pan, B.-C. Wang, H.-J. Chen, H. Sun, Z. Wang, C.-R. Xu, W.-Z. Zhong, T. Hou, D.-Q. Zhu, Q. Zhou, Y.-S. Li, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2023)
P2.09-10 Genomic Characteristics and Clonal Evolution of EGFR-mutated Lung Adenocarcinoma-Transformed Squamous Carcinoma after EGFR-TKIs Treatment
Authors: J. Kang, X.-N. Yang, L.-X. Yan, L. Yan, J.-J. Yang
Journal: Journal of Thoracic Oncology (2023)
EP09.01-07 Reverse Endobronchial Y-stent Implantation in Selected Cases of the Malignant Central Airway Obtruction
Authors: J. Pieróg, J. Szymański, M. Szaj, K. Witkiewicz, M. Wojtyś, N. Wójcik, J. Wójcik, T. Grodzki
Journal: Journal of Thoracic Oncology (2023)
EP02.03-03 The Functional and Mechanistic Role of PA28α in Lung Cancer
Authors: S.C. Tripathi, A. Pandey, M. Kobayashi, H. Katayama, J. Fahrmann, S. Pajai, C.P. Prasad, E. Ostrin, S. Hanash
Journal: Journal of Thoracic Oncology (2023)
P2.10-11 Comparative Effectiveness Analysis of Selpercatinib versus Standard Therapy in Patients with Non-small Cell Lung Cancer
Authors: D. Tan, F. De Braud, Y. Han, U. Kiiskinen, M.-H. Jen, S.S. Barker, S. Szymczak, A. Gilligan
Journal: Journal of Thoracic Oncology (2023)
EP05.01-07 Propective Study: Usefulness of D-Dimer Determination for Thromboembolic Disease Screening in Patients with Metastatic Lung Cancer
Authors: T. García Manrique, A. Gutierrez, A. Rueda, M.C. Damas, I. Fernández, C. Simarro, D. Vicente
Journal: Journal of Thoracic Oncology (2023)
EP11.02-03 First Line Sintilimab plus Anlotinib vs Platinum-based Chemotherapy in Metastatic NSCLC (SUNRISE): Updated Efficacy and Safety Analysis
Authors: T. Chu, B. Han, Z. Yu, J. Wang, Y. Zhao, X. Mu, X. Yu, X. Shi, Q. Shi, M. Guan, C. Ding, N. Geng
Journal: Journal of Thoracic Oncology (2023)
P2.23-01 An Untold Story About Living with Low Muscle Mass and its Impact Throughout Curative Radiotherapy Treatment for Lung Cancer
Authors: N. Kiss, A. Ugalde, C. Prado, L. Denehy, R. Daly, S. Siva, D. Ball, A. Wirth, G. Wheeler, S. Fraser, L. Edbrooke
Journal: Journal of Thoracic Oncology (2023)
EP08.02-22 Survival Outcome Comparison of Stage III and IV NSCLC Patients in Latvia and Israel: An Analysis of Treatment Approaches
Authors: L.C. Roisman, L. Tzivian, Z. Baltane, K. Losans, R. Velins, M. Bluzma, S. Vasiljeva, E. Vasilishina, N. Peled, E. Gasenko, A. Krams
Journal: Journal of Thoracic Oncology (2023)
EP12.01-59 Tepotinib and Capmatinib in Patients with MET exon 14 Skipping NSCLC: A Matching Adjusted Indirect Comparison (MAIC)
Authors: B.M. Pfeiffer, M.J. Postma, A. Hatswell, H. Vioix, P.K. Paik
Journal: Journal of Thoracic Oncology (2023)
P2.17-05 Characterizing Mechanisms of Treatment Resistance in SCLC
Authors: S. Devarakonda, S. Sankararaman, S. Freshour, J.P. Ward, K. Pepin, V. Puri, A. Bierhals, B. Herzog, L.B. Maggi, S.N. Waqar, D. Morgensztern, M. Griffith, O. Griffith, R. Govindan
Journal: Journal of Thoracic Oncology (2023)
EP07.02-10 Adjuvant Chemotherapy with Nanoparticle Albumin-Bound Paclitaxel and Carboplatin for Stage IB Non-small Cell Lung Cancer
Authors: Y. Motooka, K. Matsuishi, R. Maruyama, K. Yoshimoto, S. Sakata, M. Aoki, T. Marutsuka, F. Tanaka, T. Suetsugu, M. Suzuki
Journal: Journal of Thoracic Oncology (2023)
EP06.03-22 Implementing Next Generation Sequencing for Lung Cancer Patients in Mexico: A Real-World Study from Puebla
Authors: I.R. González-Espinoza, A. Castro-Ponce, A.I. Nieva-Silva, G. Juárez-Salazar, D.A. Juárez-Salazar, J.S. Montiel-Castro, M. Chiquillo-Domínguez, M. Coyotl-Huexotl, G.I. Iñíguez-López, F.d.J. Vizcarra-Ramos, S. Sánchez-Sosa, E. Miguel-Cruz, C. Aguilar-Jiménez, C.A. Cortés-García, E. Acosta-Ponce-de-León
Journal: Journal of Thoracic Oncology (2023)
EP10.01-14 Efficacy and Safety of Nintedanib and Docetaxel in Patients with Lung Adenocarcinoma: A Multicenter Real-world Analysis
Authors: M. Jakopovic, L. Ljubicic, U. Janzic, M. Unk, A.S. Terglav, K. Mohorcic, F. Seiwerth, L. Bitar, S. Badovinac, S. Plestina, M. Samarzija
Journal: Journal of Thoracic Oncology (2023)
P1.27-02 Artificial Intelligence Analysis Predicts Highly Malignant Potential in Small-Sized Lung Adenocarcinoma
Authors: Y. Kudo, J. Matsubayashi, T. Nakamura, Y. Goto, P. Jinho, S. Maehara, M. Hagiwara, M. Kakihana, T. Nagao, T. Ohira, N. Ikeda
Journal: Journal of Thoracic Oncology (2023)